SPX3,824.27-7.12 -0.19%
DIA308.78-0.93 -0.30%
IXIC11,310.66-11.58 -0.10%

Affimed Says Innate Cell Engager Induces Effective Anti-Tumor Activity in Preclinical Study

MT Newswires · 06/10/2022 08:05

Please log in to view news